metabolomics market 2023

Metabolomics Market Report - Global Forecast to 2023

pages Pages: 80
tables Tables: 18
charts Charts: 24
country Regions/Countries: 3/0
compaines Companies: 8
enqhours Enquiry Hours: 10
  • Get Free 10% Customization in this Report

COVID - 19

Covid impact updated reports at special price


Metabolomics is the identification and quantification of the complete set of metabolites in a biological system. The steps involved in metabolomics analysis are profiling, identification, quantification, and interpretation. Profiling is finding all the metabolites detectable to a selected analytical technique with the significant variations in abundance with a set of experimental and control groups. Metabolomics applications are segmented into the following: Biomarker Discovery, Drug Discovery, Personalized Medicine, Nutrigenomics, and Toxicology. The Biomarker Discovery segment generated the highest revenue in 2016, mainly due to the advancements of biomarkers metabolic profiling and diagnostic proficiencies of metabolic biomarkers for disease management at the metabolic level. The Personalized Medicine segment is expected to witness the fastest growth during the forecast period due to increasing collaborations of pharmaceutical and biotech companies for biomarker discovery and validation.

Wide range of metabolomics application in R&D and therapeutic areas is expected to drive the market. Moreover, introduction of various separation techniques to enhance the process to identification and quantification of cellular metabolites is expected to be another major factor to drive the growth of the market during the forecast period. The markets in India, China, and Japan are also expected to grow at a rapid pace during the forecast period due to refining biopharmaceutical research infrastructure, huge population, and growing healthcare requirements.

Market Analysis:

The “Global Metabolomics Market” is estimated to witness a CAGR of 13.5% during the forecast period 2017–2023. The Metabolomics market is analyzed based on two segments – applications and regions.

Regional Analysis:

The regions covered in the report are the Americas, Europe, Asia Pacific, and Rest of the World (ROW). The Americas is set to be the leading region for the metabolomics market growth followed by Europe. The Asia Pacific and ROW are set to be the emerging regions. The exclusivity of metabolomics applications for the Chinese population has led to the demand of upcoming R&D investments from MNCs in the APAC region and is expected to offer competitive edge to local players.

Key Players:

Thermo Fisher Scientific Inc., Danaher Corp., Waters corp., Agilent Technologies Inc., Shimadzu Corp., Bruker Corp., Bio-Rad Laboratories Inc. and other predominate & niche players.

Competitive Analysis:

The Metabolomics market is defined by the big MNCs. The big players along with the collaboration with other SMBs for clinical trials and R&D investments, are coming with new applications in the market, which is expected to produce double-digit growth in the upcoming years. Significant investments in R&D in this market are expected to increase and collaborations, merger & acquisition activities are expected to continue during the forecast period.


The report provides complete details about the usage and adoption rate of metabolomics in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, government initiatives towards the metabolomics adoption in the upcoming years along with the details of application areas available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

  1. Report Outline
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
    4. Report Assumptions and Declarations
  2. Executive Summary
  3. Market Positioning
    1. Total Addressable Market (TAM): Metabolomics Industry
      1. Market Overview
      2. Major Trends
      3. PESTLE Analysis
    2. Segmented Addressable Market (SAM)
    3. Related Markets
  4. Market Outlook
    1. Overview
    2. Value Chain Analysis
    3. Market Segmentation
    4. Porter 5 (Five) Forces Analysis
    5. Raw Material Analysis
    6. Patents Analysis
  5. Market Characteristics
    1. Ecosystem
    2. Market Segmentation
    3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. DRO – Impact Analysis
  6. Metabolomics Market by Techniques: Market Size and Analysis
    1. Overview
    2. Separation Techniques
    3. Detection Techniques
  7. Metabolomics Market by Application: Market Size and Analysis
    1. Overview
    2. Clinical Toxicology Testing
    3. Biomarker Discovery
    4. Nutrigenomics
    5. Drug Taxation
  8. Metabolomics Market by Regions: Market Size and Analysis
    1. Overview
    2. The Americas
    3. The EMEA Region
    4. The APAC region
    5. Rest of the World
  9. Vendor Profiles
    1. Thermo Fisher Sccientific Inc.
    2. Agilent Technologies Inc.
    3. Danaher Corp.
    4. Shimadzu Corp.
    5. Bruker Corp.
    6. LECO Corp. (Overview, products/services, geographic revenues, recent developments, business focus, SWOT analysis and business strategy for all vendors)
  10. Companies to Watch For
    1. Waters Corp.
    2. Metabolon Inc.
    3. Bio-Rad Laboratories Inc.(Overview, product coverage and potential, geographic exposure, recent developments, and business strategy for all players)
  11. Competitive Landscape
    1. Competitor Product & Geography Benchmarking
    2. Market Landscape
      1. Key Strategies Adopted
  12. What Our Peers Are Estimating
    1. Publisher 1
    2. Publisher 2
    3. Publisher 3



Research Framework

Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

Market related information is congregated from both primary and secondary sources.

Primary sources

Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.


Metabolomics Market Report - Global Forecast to 2023
Interested in this report?
Get your FREE sample now!

Select User License


Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase

Speak to our analyst
Related Reports